Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15960065rdf:typepubmed:Citationlld:pubmed
pubmed-article:15960065lifeskim:mentionsumls-concept:C0242957lld:lifeskim
pubmed-article:15960065lifeskim:mentionsumls-concept:C1334807lld:lifeskim
pubmed-article:15960065lifeskim:mentionsumls-concept:C0079414lld:lifeskim
pubmed-article:15960065lifeskim:mentionsumls-concept:C0079419lld:lifeskim
pubmed-article:15960065lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:15960065lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:15960065lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:15960065pubmed:issue5lld:pubmed
pubmed-article:15960065pubmed:dateCreated2005-6-17lld:pubmed
pubmed-article:15960065pubmed:abstractTextWe investigated the clinicopathologic and oncoprotein expression characteristics of 11 pure mucinous and 76 non-mucinous infiltrating ductal carcinomas in the human female breast. We compared patient age, tumor size, axillary lymph node status, and the expression of estrogen receptor (ER), progesterone receptor (PR), deleted-in-colon cancer (DCC), HER-2/neu, and p53. Mucinous carcinoma with axillary lymph node metastasis occurs less frequently than non-mucinous carcinoma (0% vs 63.1%; p = 0.0018). Compared with the non-mucinous type, mucinous carcinoma specimens have more DCC expression (100% vs 48.7%; p = 0.0027) and more ER expression (90.9% vs 26.9%; p = 0.0023), but less HER-2/neu overexpression (0% vs 38.1%; p = 0.0302). We confirmed that mucinous carcinoma samples from the breast reveal distinct clinicopathologic and oncoprotein expression features compared with non-mucinous carcinoma and, therefore, it seems reasonable to suggest different biologic characteristics and manifestations.lld:pubmed
pubmed-article:15960065pubmed:languageenglld:pubmed
pubmed-article:15960065pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15960065pubmed:citationSubsetIMlld:pubmed
pubmed-article:15960065pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15960065pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15960065pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15960065pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15960065pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15960065pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15960065pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15960065pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15960065pubmed:statusMEDLINElld:pubmed
pubmed-article:15960065pubmed:monthMaylld:pubmed
pubmed-article:15960065pubmed:issn1607-551Xlld:pubmed
pubmed-article:15960065pubmed:authorpubmed-author:HsuYung-Hsian...lld:pubmed
pubmed-article:15960065pubmed:authorpubmed-author:ShawCheng-Kua...lld:pubmed
pubmed-article:15960065pubmed:issnTypePrintlld:pubmed
pubmed-article:15960065pubmed:volume21lld:pubmed
pubmed-article:15960065pubmed:ownerNLMlld:pubmed
pubmed-article:15960065pubmed:authorsCompleteYlld:pubmed
pubmed-article:15960065pubmed:pagination197-202lld:pubmed
pubmed-article:15960065pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:15960065pubmed:meshHeadingpubmed-meshheading:15960065...lld:pubmed
pubmed-article:15960065pubmed:meshHeadingpubmed-meshheading:15960065...lld:pubmed
pubmed-article:15960065pubmed:meshHeadingpubmed-meshheading:15960065...lld:pubmed
pubmed-article:15960065pubmed:meshHeadingpubmed-meshheading:15960065...lld:pubmed
pubmed-article:15960065pubmed:meshHeadingpubmed-meshheading:15960065...lld:pubmed
pubmed-article:15960065pubmed:meshHeadingpubmed-meshheading:15960065...lld:pubmed
pubmed-article:15960065pubmed:meshHeadingpubmed-meshheading:15960065...lld:pubmed
pubmed-article:15960065pubmed:meshHeadingpubmed-meshheading:15960065...lld:pubmed
pubmed-article:15960065pubmed:meshHeadingpubmed-meshheading:15960065...lld:pubmed
pubmed-article:15960065pubmed:meshHeadingpubmed-meshheading:15960065...lld:pubmed
pubmed-article:15960065pubmed:meshHeadingpubmed-meshheading:15960065...lld:pubmed
pubmed-article:15960065pubmed:meshHeadingpubmed-meshheading:15960065...lld:pubmed
pubmed-article:15960065pubmed:meshHeadingpubmed-meshheading:15960065...lld:pubmed
pubmed-article:15960065pubmed:meshHeadingpubmed-meshheading:15960065...lld:pubmed
pubmed-article:15960065pubmed:meshHeadingpubmed-meshheading:15960065...lld:pubmed
pubmed-article:15960065pubmed:meshHeadingpubmed-meshheading:15960065...lld:pubmed
pubmed-article:15960065pubmed:year2005lld:pubmed
pubmed-article:15960065pubmed:articleTitleExpression of p53, DCC, and HER-2/neu in mucinous carcinoma of the breast.lld:pubmed
pubmed-article:15960065pubmed:affiliationDepartment of Pathology, Buddhist Tzu Chi General Hospital and University, Hualien, Taiwan. yhhsu@mail.tcu.edu.twlld:pubmed
pubmed-article:15960065pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15960065pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15960065lld:pubmed